Benefit-Harm Modelling: What Is This and What Can It Contribute to Pharmacovigilance

T.P. van Staa, L. Lynd, H.G.M. Leufkens, J. Raine, H. Petri

Research output: Contribution to conferenceAbstractOther research output

Original languageUndefined/Unknown
PagesS21
Number of pages1
Publication statusPublished - 17 Aug 2008
Event24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management -
Duration: 17 Aug 200820 Aug 2008

Conference

Conference24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management
Period17/08/0820/08/08

Keywords

  • Epidemiology
  • Farmacie(FARM)
  • Biomedische technologie en medicijnen
  • Ziekenhuisstructuur en organisatie van de gezondheidszorg
  • Public Health

Cite this